(2E,4E,6Z,8E)-3-Methyl-7-(p-tolyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
| CAS No. | 160162-42-5 |
|---|---|
| MDL No. | MFCD09038562 |
| MF | C26H32O2 |
| MW | 376.50 |
| InChI Key | RQANARBNMTXCDM-DKOHIBGUSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
SR11302 is a retinoid in which the methyl group at position 9 of all-trans-retinoic acid is replaced by a 4-methylphenyl group. It inhibits activator protein-1 and exhibits antitumour effects in vivo. It functions as an AP-1 antagonist and antineoplastic agent. It is a retinoid, a member of toluenes, and an alpha,beta-unsaturated monocarboxylic acid, with functional similarity to all-trans-retinoic acid.
| CAS No. | 160162-42-5 |
|---|---|
| Product Name | (2E,4E,6Z,8E)-3-Methyl-7-(p-tolyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
| Heavy Atom Count | 28 | Rotatable Bond Count | 6 |
| Atom Stereo Count | 0 | Bond Stereo Count | 4 |
| HBA | 1 | HBD | 1 |
| TPSA | 37.300 Ų | Charge | 0 |
| Exact Mass | 376.24023 | Complexity | 856.20 |
| pKa | 3.605 | XLogP | 7.048 |
